An International Registry for Biologics Used in Children with Juvenile Idiopathic Arthritis: A Challenging Collaboration Between Paediatric Rheumatologists and Pharmaceutical Industry.

NM Wulffraat; JF Swart

An International Registry for Biologics Used in Children with Juvenile Idiopathic Arthritis: A Challenging Collaboration Between Paediatric Rheumatologists and Pharmaceutical Industry.

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	106-111
Journal	Annals of Paediatric Rheumatology
Volume	1
Issue number	2
Publication status	Published - 2012

Access to Document

http://www.scopemed.org/fulltextpdf.php?mno=14864

Cite this

@article{d4427b30fb8545ee8d577465d7298b5c,

title = "An International Registry for Biologics Used in Children with Juvenile Idiopathic Arthritis: A Challenging Collaboration Between Paediatric Rheumatologists and Pharmaceutical Industry.",

author = "NM Wulffraat and JF Swart",

year = "2012",

language = "English",

volume = "1",

pages = "106--111",

number = "2",

}

TY - JOUR

T1 - An International Registry for Biologics Used in Children with Juvenile Idiopathic Arthritis: A Challenging Collaboration Between Paediatric Rheumatologists and Pharmaceutical Industry.

AU - Wulffraat, NM

AU - Swart, JF

PY - 2012

Y1 - 2012

M3 - Article

SN - 2146-2909

VL - 1

SP - 106

EP - 111

JO - Annals of Paediatric Rheumatology

JF - Annals of Paediatric Rheumatology

IS - 2

ER -